Dulaglutide vs Semaglutide
| Attribute | Dulaglutide Trulicity | Semaglutide GLP-1 receptor agonist |
|---|---|---|
| Category | Weight Loss & Metabolism | Weight Loss & Metabolism |
| Best known for | Long-acting GLP-1 agonist research | Weight loss and blood sugar research |
| In plain English | Same idea as semaglutide — long-acting GLP-1 — with a different molecular backbone. | Semaglutide mimics the hormone your gut releases when you eat. The brain reads it as 'we're full,' appetite drops, and stomach emptying slows down. |
| How it works | Activates GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying. | Activates the GLP-1 receptor in the pancreas, brain, and gut — increasing insulin secretion, slowing gastric emptying, and reducing appetite through hypothalamic signaling. |
| Researchers study | Type 2 diabetes, cardiovascular risk reduction, and weight management. | Glycemic control, weight reduction, cardiovascular outcomes, and emerging research in addiction and neuroinflammation. |
| Internet discussion | Discussed alongside semaglutide and tirzepatide on GLP-1 forums. | The internet talks about semaglutide constantly — 'Ozempic face,' food noise reduction, alcohol cravings dropping, and dose-titration questions. |
Dulaglutide
Long-acting GLP-1 agonist research
Same idea as semaglutide — long-acting GLP-1 — with a different molecular backbone.
Activates GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying.
Type 2 diabetes, cardiovascular risk reduction, and weight management.
Discussed alongside semaglutide and tirzepatide on GLP-1 forums.
Dulaglutide is a long-acting GLP-1 receptor agonist researched for glucose control and weight management.
Semaglutide
Weight loss and blood sugar research
Semaglutide mimics the hormone your gut releases when you eat. The brain reads it as 'we're full,' appetite drops, and stomach emptying slows down.
Activates the GLP-1 receptor in the pancreas, brain, and gut — increasing insulin secretion, slowing gastric emptying, and reducing appetite through hypothalamic signaling.
Glycemic control, weight reduction, cardiovascular outcomes, and emerging research in addiction and neuroinflammation.
The internet talks about semaglutide constantly — 'Ozempic face,' food noise reduction, alcohol cravings dropping, and dose-titration questions.
Semaglutide is the reference GLP-1 agonist — well-studied for blood sugar control and significant weight reduction.